E. Guttman-Yassky, “Impact of Lebrikizumab on Patient-Reported Outcomes in Atopic Dermatitis: Prospective and Post Hoc Analyses of a Phase 2b Clinical Trial Demonstrate Clinically Meaningful Improvements”, J of Skin, vol. 4, no. 6, p. s94, Oct. 2020.